"None of the active ones had fee cuts," Ullal told MarketWatch of Vanguard's actively managed fixed-income ETFs. Vanguard's active-bond ETFs are relatively small compared to the firm's passively ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

The Skillman, N.J. company expects sales to rise up to 1% or fall up to 1% in 2025, based on a 2% to 4% rise in organic sales offset by a 3% headwind from unfavorable foreign exchange rates. A 1% lift ...

Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations, and issued upbeat 2025 guidance. Fourth-quarter adjusted earnings came in at $5.32 a share, above ...